biote Corp Net Income
| BTMD Stock | USD 2.13 0.04 1.91% |
As of the 17th of February 2026, Biote Corp shows the Coefficient Of Variation of (2,145), standard deviation of 3.44, and Risk Adjusted Performance of (0.03). biote Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm biote Corp variance and value at risk to decide if biote Corp is priced correctly, providing market reflects its regular price of 2.13 per share. Please also double-check biote Corp jensen alpha, which is currently at (0.30) to validate the company can sustain itself at a future point.
Biote Corp Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.7353 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 41.4 K | 39.3 K | |
| Net Income Applicable To Common Shares | 37.5 M | 30.5 M | |
| Net Income | 41.4 K | 39.3 K | |
| Net Income Per Share | 0.11 | 0.10 | |
| Net Income Per E B T | 3.57 | 3.75 |
Biote | Net Income | Build AI portfolio with Biote Stock |
Analyzing Biote Corp's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Biote Corp's current valuation and future prospects.
Latest Biote Corp's Net Income Growth Pattern
Below is the plot of the Net Income of biote Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in biote Corp financial statement analysis. It represents the amount of money remaining after all of biote Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Biote Corp's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biote Corp's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 46 K | 10 Years Trend |
|
Net Income |
| Timeline |
Biote Net Income Regression Statistics
| Arithmetic Mean | 16,805,620 | |
| Coefficient Of Variation | 61.01 | |
| Mean Deviation | 8,586,302 | |
| Median | 21,287,000 | |
| Standard Deviation | 10,252,301 | |
| Sample Variance | 105.1T | |
| Range | 33.6M | |
| R-Value | (0.62) | |
| Mean Square Error | 68.7T | |
| R-Squared | 0.39 | |
| Significance | 0.01 | |
| Slope | (1,264,056) | |
| Total Sum of Squares | 1681.8T |
Biote Net Income History
Other Fundumenentals of biote Corp
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Biote Corp Net Income component correlations
Biote Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Biote Corp is extremely important. It helps to project a fair market value of Biote Stock properly, considering its historical fundamentals such as Net Income. Since Biote Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biote Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biote Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Biote diversify its offerings? Factors like these will boost the valuation of Biote Corp. Projected growth potential of Biote fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Biote Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.33) | Earnings Share 0.79 | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets |
biote Corp's market price often diverges from its book value, the accounting figure shown on Biote's balance sheet. Smart investors calculate Biote Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Biote Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Biote Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biote Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biote Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biote Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biote Corp.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Biote Corp on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding biote Corp or generate 0.0% return on investment in Biote Corp over 90 days. Biote Corp is related to or competes with Joint Corp, Inovio Pharmaceuticals, Spero Therapeutics, Acumen Pharmaceuticals, Seres Therapeutics, Scilex Holding, and Actuate Therapeutics. biote Corp. operates in medical practice-building business within the hormone optimization space More
Biote Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biote Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess biote Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 14.89 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 6.1 |
Biote Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biote Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biote Corp's standard deviation. In reality, there are many statistical measures that can use Biote Corp historical prices to predict the future Biote Corp's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.43) | |||
| Treynor Ratio | (0.08) |
Biote Corp February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 2.73 | |||
| Coefficient Of Variation | (2,145) | |||
| Standard Deviation | 3.44 | |||
| Variance | 11.82 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.43) | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 14.89 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 6.1 | |||
| Skewness | 0.5494 | |||
| Kurtosis | 0.0283 |
biote Corp Backtested Returns
biote Corp secures Sharpe Ratio (or Efficiency) of -0.0397, which signifies that the company had a -0.0397 % return per unit of risk over the last 3 months. biote Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biote Corp's Standard Deviation of 3.44, coefficient of variation of (2,145), and Risk Adjusted Performance of (0.03) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.15, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biote Corp will likely underperform. At this point, biote Corp has a negative expected return of -0.14%. Please make sure to confirm Biote Corp's value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if biote Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.53 |
Good reverse predictability
biote Corp has good reverse predictability. Overlapping area represents the amount of predictability between Biote Corp time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of biote Corp price movement. The serial correlation of -0.53 indicates that about 53.0% of current Biote Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.53 | |
| Spearman Rank Test | -0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Biote Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, biote Corp reported net income of 46 K. This is 99.99% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 99.99% higher than that of the company.
Biote Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biote Corp's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biote Corp could also be used in its relative valuation, which is a method of valuing Biote Corp by comparing valuation metrics of similar companies.Biote Corp is currently under evaluation in net income category among its peers.
Biote Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of Biote Corp from analyzing Biote Corp's financial statements. These drivers represent accounts that assess Biote Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Biote Corp's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 74.2M | 30.1M | 127.0M | 211.8M | 190.6M | 200.1M | |
| Enterprise Value | 84.8M | 71.3M | 152.9M | 283.3M | 255.0M | 267.7M |
Biote Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Biote Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Biote Corp's managers, analysts, and investors.Environmental | Governance | Social |
Biote Corp Institutional Holders
Institutional Holdings refers to the ownership stake in Biote Corp that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Biote Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Biote Corp's value.| Shares | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 220.7 K | Los Angeles Capital Management Llc | 2025-06-30 | 200.3 K | Renaissance Technologies Corp | 2025-06-30 | 180.4 K | Millennium Management Llc | 2025-06-30 | 131.5 K | Perritt Capital Management Inc. | 2025-06-30 | 127.8 K | Rice Hall James & Associates, Llc | 2025-06-30 | 121.7 K | Bridgeway Capital Management, Llc | 2025-06-30 | 121.1 K | Marshall Wace Asset Management Ltd | 2025-06-30 | 118.9 K | Aqr Capital Management Llc | 2025-06-30 | 111.5 K | 325 Capital Llc | 2025-06-30 | 4.5 M | Bandera Partners Llc | 2025-06-30 | 2.3 M |
Biote Fundamentals
| Return On Asset | 0.22 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 143.71 M | ||||
| Shares Outstanding | 30.68 M | ||||
| Shares Owned By Insiders | 13.34 % | ||||
| Shares Owned By Institutions | 62.86 % | ||||
| Number Of Shares Shorted | 1.62 M | ||||
| Price To Earning | 0.26 X | ||||
| Price To Book | 2.96 X | ||||
| Price To Sales | 0.52 X | ||||
| Revenue | 197.19 M | ||||
| Gross Profit | 141.58 M | ||||
| EBITDA | 15.59 M | ||||
| Net Income | 46 K | ||||
| Cash And Equivalents | 82.72 M | ||||
| Cash Per Share | 1.22 X | ||||
| Total Debt | 110.86 M | ||||
| Debt To Equity | 3.36 % | ||||
| Current Ratio | 3.23 X | ||||
| Book Value Per Share | (2.37) X | ||||
| Cash Flow From Operations | 45.24 M | ||||
| Short Ratio | 9.47 X | ||||
| Earnings Per Share | 0.79 X | ||||
| Target Price | 4.21 | ||||
| Number Of Employees | 217 | ||||
| Beta | 1.15 | ||||
| Market Capitalization | 101.92 M | ||||
| Total Asset | 122.37 M | ||||
| Retained Earnings | (100.3 M) | ||||
| Working Capital | 16.61 M | ||||
| Net Asset | 122.37 M |
About Biote Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze biote Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biote Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of biote Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether biote Corp is a strong investment it is important to analyze Biote Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biote Corp's future performance. For an informed investment choice regarding Biote Stock, refer to the following important reports:Check out For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Will Health Care Equipment & Supplies sector continue expanding? Could Biote diversify its offerings? Factors like these will boost the valuation of Biote Corp. Projected growth potential of Biote fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Biote Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.33) | Earnings Share 0.79 | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets |
biote Corp's market price often diverges from its book value, the accounting figure shown on Biote's balance sheet. Smart investors calculate Biote Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Biote Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Biote Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biote Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.